3-(5-(9-(2-(1-tert-butoxycarbonylpyrrolidin-2-yl)-3H-imidazol-4-yl)-5,7-dihydrodibenzo[c,e]oxepin-3-yl)-1H-imidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester | 1256384-62-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噁庚英
• 英文名称: 3-(5-(9-(2-(1-tert-butoxycarbonylpyrrolidin-2-yl)-3H-imidazol-4-yl)-5,7-dihydrodibenzo[c,e]oxepin-3-yl)-1H-imidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester
• 英文别名: tert-butyl (1R,3S,4S)-3-[5-[9-[2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-5,7-dihydrobenzo[d][2]benzoxepin-3-yl]-1H-imidazol-2-yl]-2-azabicyclo[2.2.1]heptane-2-carboxylate
• CAS: 1256384-62-9
• 化学式: C₄₀H₄₈N₆O₅
• 分子量: 692.858
• InChiKey: WEGHFMOLFATQTI-VVSXBHEPSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.3
• 重原子数：
  51
• 可旋转键数：
  8
• 环数：
  8.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  126
• 氢给体数：
  2
• 氢受体数：
  7

文献信息

• ANTIVIRAL COMPOUNDS
  申请人：Gilead Pharmasset LLC

  公开号：US20170029408A1

  公开（公告）日：2017-02-02

  The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.